Prostate Cancer Trial, Recruiting (NCT01194648)

Prostate Cancer Trial, Recruiting NCT01194648 Sponsor: University College, London Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT01194648 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been confirmed to have prostate cancer through a tissue sample (biopsy) taken via the rectum or through a template procedure
People whose biopsy results (from standard ultrasound-guided, MRI-targeted, or template biopsy) meet specific findings about how much cancer is present and how it looks under a microscope — including limits on which side of the prostate is affected and the cancer's grade (confirm with trial site for full details)
People whose cancer is at an early stage (T1 to T2c, or in some cases T3a on imaging), with no spread to nearby lymph nodes or other parts of the body
People whose PSA blood test result is 20 ng/ml or below
People with a life expectancy of 10 years or more
People who have signed a form giving their informed consent to take part
People who have a sufficient understanding of English to participate

Who may not be able to join:

No specific exclusion criteria were listed in the information provided (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01194648

Sponsor: University College, London

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

More information: https://clinicaltrials.gov/study/NCT01194648

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been confirmed to have prostate cancer through a tissue sample (biopsy) taken via the rectum or through a template procedure
People whose biopsy results (from standard ultrasound-guided, MRI-targeted, or template biopsy) meet specific findings about how much cancer is present and how it looks under a microscope — including limits on which side of the prostate is affected and the cancer's grade (confirm with trial site for full details)
People whose cancer is at an early stage (T1 to T2c, or in some cases T3a on imaging), with no spread to nearby lymph nodes or other parts of the body
People whose PSA blood test result is 20 ng/ml or below
People with a life expectancy of 10 years or more
People who have signed a form giving their informed consent to take part
People who have a sufficient understanding of English to participate

Who may not be able to join:

No specific exclusion criteria were listed in the information provided (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University College, London

Registry

ClinicalTrials.gov

Start date

29 June 2011

Est. completion

1 December 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Conversion to radical therapy and/or requiring systemic therapy and/or developing metastases and/or dying of prostate cancer; Conversion to radical therapy and/or requiring systemic therapy and/or developing metastases and/or dying of prostate cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov